Skip to main content

Table 3 Comparison between anthropometric and laboratory data in MetS and non-MetS obese patients

From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children

Anthropometric dataMetS (no. = 12)Non-MetS (no. = 31)p value
Height (SDS)0.523 ± 0.9710.325 ± 1.420.6
Weight (SDS)3.41 ± 1.703.06 ± 1.470.5
BMI (kg/m2)30.15 ± 3.2929.15 ± 3.550.4
BMI (SDS)3.23 ± 0.7333.08 ± 0.5600.5
Waist circumference (cm)89.61 ± 9.1685.21 ± 4.210.03*
Hip circumference (cm)95.29 ± 10.4890.96 ± 7.580.2
W/H ratio0.939 ± 0.0520.934 ± 0.0540.8
Biceps skin fold (mm)19.07 ± 5.3218.75 ± 2.990.8
Triceps skin fold (mm)26.23 ± 5.2325.00 ± 3.280.5
Subscapular skin fold (mm)25.25 ± 3.6726.48 ± 5.460.5
Systolic Bp (mmHg)121.42 ± 6.29112.90 ± 8.920.001*
Diastolic Bp (mmHg)82.92 ± 12.1575.81 ± 10.890.04*
Total cholesterol (mg/dl)171.94 ± 26.06159.25 ± 33.320.2
Triglycerides (mg/dl)125.83 ± 32.8690.71 ± 21.920.000**
HDL-c (mg/dl)40.08 ± 13.5341.68 ± 9.870.8
LDL-c (mg/dl)89.75 ± 43.91108.19 ± 25.780.2
FBS (mg/dl)103.08 ± 4.3691.00 ± 8.800.000**
Insulin (μIU/ml)19.31 ± 7.4017.15 ± 8.350.4
HOMA-IR4.89 ± 1.853.85 ± 1.930.1
PAI-155.67 ± 4.9449.84 ± 4.520.02
  1. Comparisons between groups were done using ANOVA test
  2. **p value highly significant < 0.01